Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM-IPTW cohort study - Scorecard - MDSpire
Advertisement
Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM-IPTW cohort study
Clinical Scorecard: Suboptimal Karnofsky performance status does not preclude neurosurgical resection in lung cancer patients with brain metastases: findings from a multicenter, retrospective PSM-IPTW analysis
At a Glance
Category
Detail
Condition
Lung cancer brain metastases with poor Karnofsky Performance Status (KPS ≤ 70)
Key Mechanisms
Brain metastases from lung cancer cause high morbidity and mortality; surgical resection may improve survival despite poor KPS
Target Population
Patients with lung cancer brain metastases and pretreatment KPS ≤ 70
Care Setting
Tertiary cancer centers and comprehensive hospitals
Key Highlights
Lung cancer accounts for up to 56% of brain metastases and is the most common primary cancer in BMs.
Poor KPS (≤ 70) is traditionally associated with worse outcomes and often excludes patients from surgical trials.
Multicenter retrospective analysis suggests neurosurgical resection can provide survival benefit even in patients with poor KPS.
Guideline-Based Recommendations
Diagnosis
Confirm brain metastases by enhanced MRI in patients with primary lung cancer.
Assess pretreatment Karnofsky Performance Status to stratify patient functional status.
Management
Consider neurosurgical resection for brain metastases in lung cancer patients regardless of poor KPS (≤ 70).
Use multimodal treatment including surgical resection, stereotactic radiosurgery, whole-brain radiotherapy, systemic therapy as appropriate.
Monitoring & Follow-up
Follow overall survival from date of brain metastasis diagnosis to death or last follow-up.
Collect clinical data including age, sex, smoking history, histology, EGFR/ALK status, extracranial metastases, and treatment modalities.
Risks
Poor KPS is associated with worse prognosis but should not be an absolute contraindication for surgery.
Exclude patients with overall survival less than 1 month to avoid confounding short-term mortality.
Patient & Prescribing Data
386 lung cancer patients with brain metastases and pretreatment KPS ≤ 70
Neurosurgical resection was associated with improved overall survival compared to non-surgical management after adjustment for confounders using PSM and IPTW methods.
Clinical Best Practices
Use propensity score matching and inverse probability of treatment weighting to adjust for baseline differences in retrospective analyses.
Reassess traditional surgical contraindications in light of advances in neurosurgical techniques and improved outcomes.
Exclude patients with multiple primary cancers or very short expected survival (<1 month) from surgical consideration.
